Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: European Union
US and EU Derailing Ten-year Process to Create Health Research & Development Convention
Source: Médecins Sans Frontières (MSF) 24 May 2012 The US and European Union delegations to the World Health Assembly are currently blocking efforts to move towards a binding convention on health R&D aimed at filling critical medical gaps for people … Continue reading
Posted in access to medicines, R&D, World Health Assembly
Tagged European Union, United States
Leave a comment
Minister-level meeting next month on India-EU free trade agreement
Source: Economic Times 20 May 2012 NEW DELHI: In a bid to fast track the much-delayed negotiations for the proposed free trade agreement between India and European Union, commerce minister Anand Sharma will hold comprehensive discussions with EU trade commissioner … Continue reading
Rapporteur Urges EU Parliament to Reject Anti-Counterfeiting Pact
Source: International Centre for Trade and Sustainable Development – Intellectual Property Programme 2 May 2012 The controversial Anti-Counterfeiting Trade Agreement (ACTA) hit a new roadblock last week, as ACTA rapporteur David Martin formally asked the EU Parliament to reject the … Continue reading
Posted in ACTA, IPR Enforcement, TRIPS plus, seizures, Border measures
Tagged European Union
Leave a comment
Oxfam calls on EU not to shut down ‘pharmacy of the developing world’
“At a time of declining aid budgets, efforts to increase medicine prices for the world’s poor would have a devastating impact on the achievement of health-related Millennium Development Goals.” Rohit Malpani Oxfam Policy Advisor Published: 9 February 2012 On the … Continue reading
Posted in EU-India FTA, Generic drug, Millenium Development Goals
Tagged Aids, Elton John, European Union, Oxfam
Leave a comment
Protest by AIDS activists in UK against India-EU FTA today
Affordable HIV medicines are being threatened!! 6 February 2012 After nearly four years of back and forth negotiating between the EU and India , on Friday 10th February the terms of the free trade agreement (FTA) will be announced at the EU-India Summit … Continue reading
Poser over medicine supplies:GLOBAL TRENDS
By MARTIN KHOR Source: The Star January 9, 2012 Patients worldwide suffering from various ailments have benefited from cheap generic Indian drugs. But will Indian companies be able to supply new drugs in the future? INDIA may be more famous … Continue reading
Intense talks to continue on India-EU FTA next week
Source: Economic Times PTI Nov 18, 2011, 07.20pm IST NEW DELHI: The European Union today said it wants an “ambitious”free trade agreement with India which would be of benefit to both the sides which are working full steam to find solutions to certain … Continue reading
European Commission – Press release – Antitrust: Commission opens proceedings against Johnson & Johnson and Novartis
Source: European C0mmission Brussels, 21 October 2011 – The European Commission has opened an antitrust investigation, on its own initiative, to assess whether contractual arrangements between US-based pharmaceutical company Johnson & Johnson and the generic branches of the Swiss-based company … Continue reading
Posted in Generic drug
Tagged European Commission, European Union, Fentanyl, Johnson, Novartis
Leave a comment
